Data-driven medicine company SOPHiA GENETICS has completed the acquisition of French tech company Interactive Biosoftware (IBS).

IBS created Alamut, which is said to be the most used decision support software for clinical genomic data interpretation.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Currently deployed in more than 450 hospitals, the software is complementary to SOPHiA GENETICS’ offering.

“With the latest acquisition, SOPHiA GENETICS will be able to reinforce its proposal to continuously support hospitals and patients with powerful technologies.”

The acquisition is aimed at further accelerating the adoption of data-driven medicine across the globe.

Interactive Biosoftware CEO and founder André Blavier said: “Interactive Biosoftware has been highly successful in providing powerful technology for experts with complex genomic interpretation needs.

“It is great to join SOPHiA GENETICS unique approach and position to accelerate Data-Driven Medicine’s adoption.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

With the latest acquisition, SOPHiA GENETICS will be able to reinforce its proposal to continuously support hospitals and patients with powerful technologies.

Following the deal, Interactive Biosoftware’s expertise and teams are set to join SOPHiA GENETICS’ workforce.

SOPHiA GENETICS CEO and co-founder Jurgi Camblong said: “We are very excited about the acquisition of Interactive Biosoftware. Both SOPHiA AI and Alamut are technologies trusted by the healthcare community and focus on patient-centric innovation.

“The addition of Alamut marks a big step in our aim to help clinicians better diagnose patients equally. With a community of now over 900 teaching hospitals using our technologies we are in a unique position to connect clinicians and enable them to share knowledge.”

SOPHiA GENETICS has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact